Skip to Content



Biogen CEO on Controversial Alzheimer's Drug: "There Is Hope"

April 28, 2020 20:33 PM UTC
- Updated April 28, 2020 20:34 PM UTC

CEO Michel Vounatsos says if the drug is approved it will require new payment innovations to make it affordable for the people who need it.